Skip Nav Destination
Issues
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Roy Elias; Thomas Nirschl; Michael Rezaee; Anirudh Yerrapragada; Shirley Wang; Joseph Cheaib; Ridwan Alam; Sunil Patel; Yuezhou Jing; Mohamad Allaf; David McKean; Alison P. Klein; Elana J. Fertig; Ezra Baraban; Yasser Ged; Srinivasan Yegnasubramanian; Nirmish Singla
Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
Glenn J. Hanna; Gregory M. Cote; Rashmi Chugh; Jacob S. Thomas; Jyoti Malhotra; Richard E. Cutler; Tressa Hood; Luis A. Carvajal; Elizabeth A. Olek; Miguel A. Villalona-Calero
Preclinical Activity of Datopotamab Deruxtecan, an Antibody–Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma
Michelle Greenman; Cem Demirkiran; Stefania Bellone; Tobias M.P. Hartwich; Blair McNamara; Victoria M. Ettorre; Niccolo G. Santin; Namrata Sethi; Yang Yang-Hartwich; Katyayani Papatla; Elena Ratner; Alessandro D. Santin
Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2, and PALB2
Allison W. Kurian; Elisha Hughes; Ryan Bernhisel; Eudora Hu; Eric C. Polley; Siddhartha Yadav; Chunling Hu; Jennifer L. Caswell-Jin; Esther M. John; Aladdin H. Shadyab; Rowan Chlebowski; Rami Nassir; Peter Kraft; Marcia L. Stefanick; Fergus J. Couch
Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Abigail E. Lantz; Edna R. Gordián; Marilin Rosa; Marileana Rodríguez-Ruíz; Joseph O. Johnson; Ryan Gebert; Allison Bahr; Dung Tsa Chen; Julie Dutil; Jiannong Li; José A. Oliveras Torres; Harold I. Saavedra; Steven A. Eschrich; Idhaliz Flores; William D. Cress
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma
Gwendolyn M. Cramer; Richard W. Davis, IV; Emmanouil Papasavvas; Astero Klampatsa; Joann M. Miller; Shirron Carter; Ruth Ikpe; Min Yuan; Sandy Widura; R. Sonali Majumdar; Sally McNulty; Mary Putt; Andrew V. Kossenkov; Luis J. Montaner; Sunil Singhal; Edmund K. Moon; Steven M. Albelda; Keith A. Cengel; Theresa M. Busch
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
Kentaro Sawada; Riu Yamashita; Shunsuke A. Sakai; Satoshi Horasawa; Ayumu Yoshikawa; Takao Fujisawa; Shigenori Kadowaki; Ken Kato; Makoto Ueno; Eiji Oki; Yoshito Komatsu; Tatsuyuki Chiyoda; Yosuke Horita; Hisateru Yasui; Tadamichi Denda; Hironaga Satake; Taito Esaki; Taroh Satoh; Naoki Takahashi; Kentaro Yamazaki; Nobuhisa Matsuhashi; Tomohiro Nishina; Hiroyuki Takeda; Koushiro Ohtsubo; Takashi Ohta; Akihito Tsuji; Masahiro Goto; Takeshi Kato; Hideaki Bando; Katsuya Tsuchihara; Yoshiaki Nakamura; Takayuki Yoshino
P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Bernat Navarro-Serer; Maria F. Wissler; Brandi K. Glover; Michael G. Lerner; Harsh H. Oza; Vania Wang; Hidur Knutsdottir; Fatemeh Shojaeian; Kathleen Noller; Saravana Gowtham Baskaran; Sarah Hughes; Alana M. Weaver; Daniel Wilentz; Oluwatobiloba Olayemi; Joel S. Bader; Elana J. Fertig; Daniele M. Gilkes; Laura D. Wood
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds
